Crossref

1. RUNX1 knockdown induced apoptosis and impaired EMT in high-grade serous ovarian cancer cells

- Yuanzhi Chen

- Zhicheng He

- Shuting Yang

- Cheng Chen

- Wenyong Xiong

- YingYing He

- Shubai Liu

2. Selection and Evaluation of Human Recombinant Antibodies against ErbB2 Antigen for Breast Cancer Immunotherapy

- Elham Nadimi

- Foroogh Nejatollahi

3. Prognostic significance of positive peritoneal cytology in endometrial cancer patients

- Nadereh Behtash

- Shahrzad Sheikhhasani

- Vahid Nezamabadi

4. Dysregulation of gene expression of PTEN and AKT signaling pathway in patients of ovarian cancer: A pilot study

- Laraib Zara

- Rizwana Hussain

- Muhammad Shareef Masoud

- Nadia Naseem

- Hafiz Usman Ahmad

- Usman Ali Ashfaq

- Saba Khaliq

5. Anti-Proliferative Effects of Human Anti-FZD7 Single Chain Antibodies on Colorectal Cancer Cells

- Mehdi Fazeli

- Neda Zarei

- Bahareh Moazen

- Foroogh Nejatollahi

6. Production of Specific Anti-EGFR Single Chain Antibodies: A Promising Strategy in the Immunotherapy of EGFR Expressing Tumor Tissues

- S. Saeed Mohammadi

- Farideh Hosseinzadeh

- Foroogh Nejatollahi

7. Up-regulation of long non-coding RNA SNHG20 promotes ovarian cancer progression via Wnt/β-catenin signaling

- Shanyang He

- Yunhe Zhao

- Xiaoping Wang

- Yalan Deng

- Zhiyong Wan

- Shuzhong Yao

- Hongwei Shen

8. Non-coding RNAs in gynecologic cancer

- Arezoo Solati

- Sina Thvimi

- Seyyed Hossein Khatami

- Zahra Shabaninejad

- Yalda Malekzadegan

- Mehdi Alizadeh

- Pegah Mousavi

- Mortaza Taheri-Anganeh

- Damoun Razmjoue

- Sedigheh Bahmyari

- Hojat Ghasemnejad-Berenji

- Asma Vafadar

- Elahe Soltani Fard

- Hassan Ghasemi

- Ahmad Movahedpour

9. Cancer-Testis Antigens: A Novel Group of Tumor Biomarkers in Ovarian Cancers

- Zahra Taherian-Esfahani

- Atieh Abedin-Do

- Elahe Nikpayam

- Behnoosh Tasharofi

- Akram Ghahghaei Nezamabadi

- Soudeh Ghafouri-Fard

10. Progression inference for somatic mutations in cancer

- Leif E. Peterson

- Tatiana Kovyrshina

11. Molecular Subtyping of Serous Ovarian Cancer Based on Multi-omics Data

- Zhe Zhang

- Ke Huang

- Chenglei Gu

- Luyang Zhao

- Nan Wang

- Xiaolei Wang

- Dongsheng Zhao

- Chenggang Zhang

- Yiming Lu

- Yuanguang Meng

12. Positive Peritoneal Cytology as a Predictor of Prognosis in Early Stage of Endometrioid Adenocarcinoma

- Setare Akhavan

- Zohre Kazemi

- Abbas Alibakhshi

- Mitra Modaresgilani

- Azamsadat Mousavi

- Azar Ahmadzadeh

- Khadije Rezaie Kahkhayi

13. LINK-A long non-coding RNA and VEGF RNA expression in epithelial ovarian cancer patients

- Parichehr Maleki

- Sadaf Valeh Sheida

- Seyed Javad Mowla

- Vahid Soleimani

- Mohammad Taheri

- Jamshid Raheb

14. Cell growth inhibition and apoptotic effects of a specific anti-RTFscFv antibody on prostate cancer, but not glioblastoma, cells

- Foroogh Nejatollahi

- Payam Bayat

- Bahareh Moazen

15. Uncovering miRNA–mRNA Regulatory Networks Related to Olaparib Resistance and Resensitization of BRCA2MUT Ovarian Cancer PEO1-OR Cells with the ATR/CHK1 Pathway Inhibitors

- Łukasz Biegała

- Damian Kołat

- Arkadiusz Gajek

- Elżbieta Płuciennik

- Agnieszka Marczak

- Agnieszka Śliwińska

- Michał Mikula

- Aneta Rogalska

16. Specific Single Chain Antibodies Against A Neuronal Growth Inhibitor Receptor, Nogo Receptor 1: Promising New Antibodies for the Immunotherapy of Multiple Sclerosis

- Bahareh Ehsaei

- Foroogh Nejatollahi

- Mozafar Mohammadi

17. Polyisoprenylated Cysteinyl Amide Inhibitors: A Novel Approach to Controlling Cancers with Hyperactive Growth Signaling

- Nazarius S. Lamango

- Augustine T. Nkembo

- Elizabeth Ntantie

- Nada Tawfeeq